Casma Therapeutics

Casma Therapeutics is a privately held clinical-stage biotechnology company founded in 2018 and headquartered at 201 Brookline Ave, Suite 1401, Boston, MA. Casma develops novel cellular degradation medicines built on the autophagy pathway — the conserved process cells use to clear damaged components. Its PHLYT (Phagosome-Lysosome Targeting) platform initiates target-specific autophagic degradation of disease targets independent of size or complexity, reaching beyond single proteins to organelles, protein aggregates and large signaling complexes, with programs spanning oncology, inflammation, neurodegeneration and metabolic disease. Casma was named to the Fierce 15 list in 2019. The company publishes no public developer API, developer portal, SDKs or machine-readable API contract; it is catalogued here as a company profile only.

Casma Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Drug Discovery.

Casma Therapeutics’ developer surface includes engineering blog and 14 more developer resources.

🌐 Visit website 📡 Source on GitHub
12.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-05 · rubric v0.9.1
0 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesDrug DiscoveryTherapeuticsAutophagyHealth

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-05 · rubric v0.9.1
Composite quality — 12.4/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.9 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/casma-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Casma Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 6

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 Careers
Careers
 Investors
Investors
 LinkedIn
LinkedIn

Other 4

Properties that don't map to a standard resource type

Team
Team
 Science
Science
 Pipeline
Pipeline
 SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: casma-therapeutics
name: Casma Therapeutics
description: Casma Therapeutics is a privately held clinical-stage biotechnology company founded in 2018 and headquartered
  at 201 Brookline Ave, Suite 1401, Boston, MA. Casma develops novel cellular degradation medicines built on the autophagy
  pathway — the conserved process cells use to clear damaged components. Its PHLYT (Phagosome-Lysosome Targeting) platform
  initiates target-specific autophagic degradation of disease targets independent of size or complexity, reaching beyond single
  proteins to organelles, protein aggregates and large signaling complexes, with programs spanning oncology, inflammation,
  neurodegeneration and metabolic disease. Casma was named to the Fierce 15 list in 2019. The company publishes no public
  developer API, developer portal, SDKs or machine-readable API contract; it is catalogued here as a company profile only.
image: https://www.casmatx.com/wp-content/themes/casma/images/brand-logo.svg
url: https://raw.githubusercontent.com/api-evangelist/casma-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
x-enrichment:
  date: '2026-08-02'
  status: minimal
  artifacts_added: 3
  pass: local-v1
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Drug Discovery
- Therapeutics
- Autophagy
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/casma-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/casma-therapeutics-llms.txt
- type: Website
  url: https://www.casmatx.com/
- type: About
  url: https://www.casmatx.com/about/
- type: Contact
  url: https://www.casmatx.com/contact-us/
- type: Blog
  url: https://www.casmatx.com/news-media/
- type: PrivacyPolicy
  url: https://www.casmatx.com/privacy-policy/
- type: TermsOfService
  url: https://www.casmatx.com/terms-of-use/
- type: Careers
  url: https://www.casmatx.com/careers-culture/
- type: Investors
  url: https://www.casmatx.com/investors/
- type: Team
  url: https://www.casmatx.com/our-team/
- type: Science
  url: https://www.casmatx.com/science/
- type: Pipeline
  url: https://www.casmatx.com/platform-pipeline/
- type: LinkedIn
  url: https://www.linkedin.com/company/casma-tx
- type: SecondaryMarket
  url: https://forgeglobal.com/casma-therapeutics_stock/